The Prevention & Early Detection Cluster is proud to announce the release of its second newsletter, showcasing groundbreaking progress across key research projects, including DIOPTRA, LUCIA, MammoScreen, ONCOSCREEN, PANCAID, and SANGUINE. These initiatives collectively contribute to the ambitious Mission Cancer, which aims to enhance the quality of life for over 3 million people by 2030.
Each project within the cluster leverages cutting-edge technology while prioritising patient comfort, both physical and psychological. For example, PANCAID is making remarkable strides in the early detection of pancreatic cancer with liquid biopsy, developing a minimally invasive blood test. This approach has the potential to identify cancer in its initial stages, significantly improving treatment outcomes.
Another highlight is the work done by the SANGUINE project, which focuses on the discovery of cancer biomarkers and the development of HemaChip technology. This pioneering work aims to provide more accurate diagnostics and a simple, affordable solution for cancer diagnosis.
The newsletter also features:
- A captivating new video series spotlighting the diverse expertise of DIOPTRA’s partners.
- Details of ONCOSCREEN’s latest strategic partnership, underscoring its commitment to advancing cancer screening.
- A summary of MammoScreen’s recent consortium meeting, highlighting collaborative efforts and shared insights.
- An open call announcement from project LUCIA, inviting engagement and participation.
These projects are a testament to the collective commitment to pushing the boundaries of cancer research and innovation. Dive into the full newsletter to explore how these efforts are reshaping early detection and prevention in oncology!
